Biostax Corp. (BTAX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 19, 2026, 9:30 AM EST
Biostax Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | - | 0.03 | 0.15 | 0.49 | 0.01 | 0 |
Short-Term Investments | - | - | - | 2.65 | - | - |
Cash & Short-Term Investments | - | 0.03 | 0.15 | 3.14 | 0.01 | 0 |
Cash Growth | - | -80.21% | -95.21% | 31380.14% | 102.46% | -15.94% |
Total Current Assets | - | 0.03 | 0.15 | 3.14 | 0.01 | 0 |
Property, Plant & Equipment | - | - | - | - | - | 0 |
Other Intangible Assets | - | - | 0.76 | - | - | - |
Other Long-Term Assets | 0.01 | 0.01 | 0.05 | - | 0 | 0 |
Total Assets | 0.01 | 0.04 | 0.96 | 3.14 | 0.01 | 0.01 |
Liabilities
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Accounts Payable | 1.26 | 1.21 | 1.3 | 2.18 | 2.56 | 2.66 |
Accrued Expenses | 0.85 | 0.76 | 0.54 | 4.23 | 4.76 | 4.65 |
Short-Term Debt | 1.16 | 1.13 | 0.7 | 3.79 | 2.84 | - |
Current Portion of Long-Term Debt | - | - | - | - | - | 5.55 |
Other Current Liabilities | 2.06 | 1.46 | 0.94 | 0.89 | 1.51 | 0.85 |
Total Current Liabilities | 5.33 | 4.56 | 3.48 | 11.09 | 11.68 | 13.69 |
Total Liabilities | 5.33 | 4.56 | 3.48 | 11.09 | 11.68 | 13.69 |
Shareholders' Equity
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 |
Additional Paid-In Capital | 380.82 | 380.8 | 380.44 | 371.47 | 371.34 | 370.91 |
Retained Earnings | -386.15 | -385.33 | -382.97 | -379.43 | -383.02 | -384.61 |
Comprehensive Income & Other | - | - | 0.01 | 0.01 | 0.01 | 0.01 |
Total Common Equity | -5.32 | -4.53 | -2.51 | -7.95 | -11.67 | -13.69 |
Shareholders' Equity | -5.32 | -4.53 | -2.51 | -7.95 | -11.67 | -13.69 |
Total Liabilities & Equity | 0.01 | 0.04 | 0.96 | 3.14 | 0.01 | 0.01 |
Additional Metrics
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Total Debt | 1.16 | 1.13 | 0.7 | 3.79 | 2.84 | 5.55 |
Net Cash (Debt) | -1.16 | -1.1 | -0.55 | -0.65 | -2.83 | -5.54 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.01 | -0.01 | -0.02 | -0.07 | -5.95 | -12.11 |
Filing Date Shares Outstanding | 78.71 | 83.74 | 83.3 | 0.48 | 0.48 | 0.46 |
Total Common Shares Outstanding | 84.35 | 83.66 | 83.05 | 0.48 | 0.48 | 0.46 |
Working Capital | -5.33 | -4.53 | -3.33 | -7.95 | -11.67 | -13.69 |
Book Value Per Share | -0.06 | -0.05 | -0.03 | -16.43 | -24.48 | -29.92 |
Tangible Book Value | -5.32 | -4.53 | -3.28 | -7.95 | -11.67 | -13.69 |
Tangible Book Value Per Share | -0.06 | -0.05 | -0.04 | -16.43 | -24.48 | -29.92 |
Machinery | - | - | - | - | - | 0.01 |